MSF Field Research > 1 Published Research and Commentary > Leishmaniasis/Kala Azar > Browsing MSF

Browsing "Leishmaniasis/Kala Azar" by Issue Date

Jump to a point in the index:
Or type in a year:

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 20 of 67
Issue DateTitleAuthor(s)
10-Mar-2015 Epidemiological Changes in Leishmaniasis in Spain According to Hospitalization-Based Records, 1997-2011: Raising Awareness towards Leishmaniasis in Non-HIV PatientsHerrador, Zaida; Gherasim, Alin; Jimenez, B Carolina; Granados, Marisol; San Martín, Juan Victor; Aparicio, Pilar
30-Nov-2014 Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challengePatole, Shalom; Burza, Sakib; Varghese, George M.
11-Sep-2014 Visceral Leishmaniasis Relapse in HIV Patients-A Role for Myeloid-Derived Suppressor Cells?Van den Bergh, Rafael; Van Ginderachter, Jo A; Schouppe, Elio; Desimmie, Belete A; Hailu, Asrat; De Baetselier, Patrick; van Griensven, Johan
15-Aug-2014 HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination.Burza, Sakib; Mahajan, Raman; Sanz, Marta Gonzalez; Sunyoto, Temmy; Kumar, Ranjeet; Mitra, Gaurab; Lima, María Angeles; Medecins Sans Frontieres
7-Aug-2014 Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome).Burza, Sakib; Mahajan, Raman; Sinha, Prabhat K; van Griensven, Johan; Pandey, Krishna; Lima, María Angeles; Sanz, Marta Gonzalez; Sunyoto, Temmy; Kumar, Sunil; Mitra, Gaurab; Kumar, Ranjeet; Verma, Neena; Das, Pradeep
7-Aug-2014 A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?van Griensven, Johan; Diro, Ermias; Lopez-Velez, Rogelio; Ritmeijer, Koert; Boelaert, Marleen; Zijlstra, Ed E; Hailu, Asrat; Lynen, Lutgarde
Aug-2014 Different Liposomal Amphotericin B Formulations for Visceral LeishmaniasisDorlo, Thomas P C; Balasegaram, Manica
17-Jul-2014 Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelinesvan Griensven, Johan; Ritmeijer, Koert; Lynen, Lutgarde; Diro, Ermias
26-Jun-2014 Visceral Leishmaniasis and HIV Coinfection in East AfricaDiro, Ermias; Lynen, Lutgarde; Ritmeijer, Koert; Boelaert, Marleen; Hailu, Asrat; van Griensven, Johan
12-Jun-2014 Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh-A Case ReportMarking, Ulrika; den Boer, Margriet; Das, Asish Kumar; Ahmed, Elshafie Mohamed; Rollason, Victoria; Ahmed, Be-Nazir; Davidson, Robert N; Ritmeijer, Koert
10-May-2014 Visceral leishmaniasis and HIV co-infection in Bihar, India: a wake-up call?van Griensven, Johan
21-Mar-2014 Active and passive case detection strategies for the control of leishmaniasis in BangladeshDas, A. K.; Harries, A. D.; Hinderaker, S. G.; Zachariah, R; Ahmad, B; Shah, G. N.; Khogali, M. A.; Das, G. I.; Ahmed, E. M.; Ritmeijer, K
Feb-2014 Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?Salih, Niven A; van Griensven, Johan; Chappuis, François; Antierens, Annick; Mumina, Ann; Hammam, Omar; Boulle, Philippa; Alirol, Emilie; Alnour, Mubarak; Elhag, Mousab S; Manzi, Marcel; Kizito, Walter; Zachariah, Rony
Jan-2014 Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, IndiaBurza, Sakib; Sinha, Prabhat K; Mahajan, Raman; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Balsegaram, Manica; Das, Pradeep
Jan-2014 Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, IndiaBurza, Sakib; Sinha, Prabhat Kumar; Mahajan, Raman; Sanz, Marta González; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Das, Pradeep
Jan-2014 Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, IndiaBurza, Sakib; Sinha, Prabhat K; Mahajan, Raman; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Balasegarem, Manica; Das, Pradeep
11-Nov-2013 Clinical Epidemiology, Diagnosis and Treatment of Visceral Leishmaniasis in the Pokot Endemic Area of Uganda and KenyaMueller, Yolanda K; Kolaczinski, Jan H; Koech, Timothy; Lokwang, Peter; Riongoita, Mark; Velilla, Elena; Brooker, Simon J; Chappuis, François; Epicentre, Paris, France; Faculty of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom; Médecins Sans Frontières, Operational Centre, Geneva, Switzerland; Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Nov-2013 One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, IndiaBurza, Sakib; Nabi, Emara; Mahajan, Raman; Mitra, Gaurab; Lima, María Angeles
26-Sep-2013 Validation of Two Rapid Diagnostic Tests for Visceral Leishmaniasis in KenyaMbui, Jane; Wasunna, Monique; Balasegaram, Manica; Laussermayer, Adrian; Juma, Rashid; Njenga, Simon Njoroge; Kirigi, George; Riongoita, Mark; de la Tour, Roberto; van Peteghem, Joke; Omollo, Raymond; Chappuis, François
11-Dec-2012 Liposomal amphotericin B as a treatment for human leishmaniasisBalasegaram, Manica; Ritmeijer, Koert; Lima, Maria Angeles; Burza, Sakib; Ortiz Genovese, Gemma; Milani, Barbara; Gaspani, Sara; Potet, Julien; Chappuis, François; Drugs for Neglected Diseases Initiative, Geneva, Switzerland;2 Médecins Sans Frontières, Operational Centre Amsterdam, Amsterdam, The Netherlands; Médecins Sans Frontières, Operational Centre Barcelona Athens, Barcelona, Spain; Médecins Sans Frontières, Access Campaign, Paris, France; Médecins Sans Frontières, Operational Centre Geneva, Geneva, Switzerland;Médecins Sans Frontières, Access Campaign, Geneva, Switzerland; University of Geneva, andGeneva University Hospitals, Division of International and Humanitarian Medicine, 6, rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland.
Showing results 1 to 20 of 67


OR Logo Powered by Open Repository | Cookies


MSF logo MSF Field Research

Mar 28, 2015